$41.85
-0.53[-1.25%]
Last update: 3:14PM Get Real Time Here
SpringWorks Therapeutics
(NASDAQ:SWTX)Latest News for SpringWorks Therapeutics Stock (NASDAQ:SWTX)
SpringWorks Therapeutics Stock (NASDAQ: SWTX)
Categories: All
Monday, May 06, 2024
Thursday, May 02, 2024
- SpringWorks shares are trading lower after the company reported worse-than-expected Q1 EPS results.Benzinga Newsdesk - May 2, 2024, 10:52AM
- Springworks' Cash, Cash Equivalents And Marketable Securities Were $573M As Of March 31, 2024Benzinga Newsdesk - May 2, 2024, 6:35AM
- SpringWorks Therapeutics Q1 2024 GAAP EPS $(1.18) Misses $(1.16) Estimate, Sales $21.006M Beat $12.206M EstimateBenzinga Newsdesk - May 2, 2024, 6:32AM
Wednesday, March 06, 2024
Thursday, February 29, 2024
- SpringWorks Therapeutics Announces European Medicines Agency Validation For Marketing Authorization Application Of Nirogacestat For Treatment Of Adults With Desmoid TumorsBenzinga Newsdesk - Feb 29, 2024, 9:02AM
- Barclays Maintains Overweight on SpringWorks Therapeutics, Raises Price Target to $63Benzinga Newsdesk - Feb 29, 2024, 8:26AM
Tuesday, February 27, 2024
- SpringWorks Therapeutics shares are trading higher after the company reported Q4 financial results.Benzinga Newsdesk - Feb 27, 2024, 11:48AM
- SpringWorks Therapeutics: Q4 Earnings InsightsBenzinga Insights - Feb 27, 2024, 9:00AM
- SpringWorks Therapeutics Reported Q4 OGSIVEO Net Product Revenues of $5.4M, EPS Loss of $(1.44) Vs $(1.19) YoY, Cash of $662.6MBenzinga Newsdesk - Feb 27, 2024, 6:39AM
Monday, February 26, 2024
Tuesday, February 20, 2024
Friday, February 16, 2024
- SpringWorks Therapeutics shares are trading higher amid a rumor that suggests a company is seeing takeover interest.Benzinga Newsdesk - Feb 16, 2024, 3:35PM
- Watching SpringWorks Therapeutics; Traders Circulate Unconfirmed Note Suggesting Company Seeing Takeover InterestBenzinga Newsdesk - Feb 16, 2024, 11:48AM
Thursday, January 25, 2024
Friday, January 19, 2024
Tuesday, December 12, 2023
Tuesday, December 05, 2023
Monday, December 04, 2023
Thursday, November 30, 2023
Wednesday, November 29, 2023
- SpringWorks Therapeutics shares are trading higher after HC Wainwright and Goldman Sachs maintained the stock with a Buy rating and raised their respective price targets.Benzinga Newsdesk - Nov 29, 2023, 11:47AM
- Goldman Sachs Maintains Buy on SpringWorks Therapeutics, Raises Price Target to $52Benzinga Newsdesk - Nov 29, 2023, 9:12AM
- Analyst Ratings for SpringWorks TherapeuticsBenzinga Insights - Nov 29, 2023, 8:00AM
- HC Wainwright & Co. Maintains Buy on SpringWorks Therapeutics, Raises Price Target to $73Benzinga Newsdesk - Nov 29, 2023, 6:50AM
Tuesday, November 28, 2023
- Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Nov 28, 2023, 2:44PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Nov 28, 2023, 12:30PM
- SpringWorks Therapeutics shares are trading higher after the company announced FDA approval of OGSIVEO.Benzinga Newsdesk - Nov 28, 2023, 11:50AM
- PDD Posts Upbeat Revenue, Joins Avidity Biosciences, SpringWorks Therapeutics And Other Big Stocks Moving Higher On TuesdayLisa Levin - Nov 28, 2023, 9:39AM
- HC Wainwright & Co. Maintains Buy on SpringWorks Therapeutics, Raises Price Target to $64Benzinga Newsdesk - Nov 28, 2023, 9:33AM
- Why SpringWorks Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving PremarketLisa Levin - Nov 28, 2023, 7:56AM
- FDA Approves SpringWorks Therapeutics' Lead Therapy As First For Subtype Of Soft Tissue SarcomasVandana Singh - Nov 28, 2023, 6:43AM
Monday, November 27, 2023
Monday, November 20, 2023
Thursday, November 16, 2023
Thursday, November 09, 2023
Thursday, November 02, 2023
Thursday, August 24, 2023
- SpringWorks' Investigational Cancer Treatment Is Standard Care, Analyst Unfazed By FDA UpdateVandana Singh - Aug 24, 2023, 2:35PM
- Analyst Ratings for SpringWorks TherapeuticsBenzinga Insights - Aug 24, 2023, 8:00AM
- HC Wainwright & Co. Reiterates Buy on SpringWorks Therapeutics, Maintains $66 Price TargetBenzinga Newsdesk - Aug 24, 2023, 6:22AM